Page last updated: 2024-10-31

midazolam and Death, Sudden, Cardiac

midazolam has been researched along with Death, Sudden, Cardiac in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Death, Sudden, Cardiac: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaya, E1
Jánosi, RA1
Azizy, O1
Wakili, R1
Rassaf, T1

Other Studies

1 other study available for midazolam and Death, Sudden, Cardiac

ArticleYear
Conscious sedation during subcutaneous implantable cardioverter-defibrillator implantation using the intermuscular technique.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2019, Volume: 54, Issue:1

    Topics: Adult; Aged; Anesthesia, Local; Cohort Studies; Conscious Sedation; Death, Sudden, Cardiac; Defibril

2019